Monday, August 19, 2019
News
NEWS HOME
PRN INDIA
Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias
  SocialTwist Tell-a-Friend  
   

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2019

LOS ANGELES, July 15, 2019 /PRNewswire/ -- Significant advances in the global search for blood test technologies for Alzheimer's disease and other dementias were reported at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles.

A new report at AAIC 2019 describes methods for measuring abnormal versions of amyloid protein, which is the building block of one of the hallmark brain lesions of Alzheimer's disease, in blood and correlating it with established Alzheimer's markers. Two additional reports describe new blood-based methods for assessing alpha synuclein, which contributes to the brain changes of Parkinson's disease and Dementia with Lewy Bodies, and neurofilament light, which may turn out to be the most reliable indicator of general brain cell damage.

Currently, the brain changes that occur before Alzheimer's dementia symptoms appear can only be reliably assessed by positron-emission tomography (PET) scans, and from measuring amyloid and tau proteins in spinal fluid. These methods are expensive and, in the case of a spinal tap, invasive. And, too often, they are unavailable, not covered by insurance or difficult to access.

There is a global "race" to uncover and develop new screening and diagnostic tools for Alzheimer's disease, such as a blood test.

"There is a great need for simple, reliable, inexpensive, non-invasive and easily available diagnostic tools for Alzheimer's," said Maria C. Carrillo, PhD, Alzheimer's Association chief science officer. "Families facing Alzheimer's now and in the future would benefit greatly from simple and widely accessible diagnostic tools that enable accurate diagnosis, earlier in the disease process, allowing for important care and planning."

"These new testing technologies, which are currently under development by industry and academic researchers, could also potentially be used to track the impact of therapies in clinical trials," Carrillo added.

How Does Plasma Amyloid Compare with Other Alzheimer's Biomarkers?
In a study published in Nature in January 2018, Akinori Nakamura, MD, PhD, of the National Center for Geriatrics and Gerontology, Obu, Japan and colleagues described a potential blood biomarker of amyloid-beta which they suggested might allow identification of people likely to develop Alzheimer's dementia in the future. The technology measures plasma levels of amyloid-related peptides (Aβ1-42, Aβ1-40, and APP669-711), and the biomarker is generated by combining the ratios of the peptides (APP669-711/Aβ1-42 and Aβ1-40/Aβ1-42).

At AAIC 2019, Nakamura and colleagues reported results of a study aimed at analyzing the plasma biomarker in comparison to brain amyloid PET scans (reflecting Aβ deposition), structural MRI (reflecting brain atrophy), FDG-PET (reflecting glucose hypometabolism) and behavioral tests (MMSE/reflecting cognitive decline). They analyzed 201 samples (70 cognitively normal, 46 MCI, 61 Alzheimer's, and 24 non-Alzheimer's dementia) from three different institutes in Japan.

The composite blood biomarker values were significantly correlated with amyloid PET values (p<0.001), MRI (p<0.001), FDG-PET (p<0.002), and MMSE (p<0.001).

"We found that the plasma biomarker can detect earlier stages of amyloid deposition, even before dementia symptoms are apparent," Nakamura said. "Our results suggest that the plasma biomarker may be useful in screening people who are at risk for Alzheimer's. This can facilitate clinical trials for Alzheimer's therapies, and also accelerate studies to investigate the effects of non-drug interventions, risk management, and lifestyles on Alzheimer's progression."

Alpha Synuclein (a Lewy Body Marker), Amyloid and Tau in Red Blood Cells
A common feature of many degenerative brain diseases is accumulation of "misfolded proteins," including α-synuclein (α-syn), amyloid-beta (Aβ) and tau, in both the brain and peripheral fluids. Recently, the physical interaction of α-syn with amyloid and tau has been suggested to be involved in the cause and progression of these diseases.

Abnormal versions of amyloid and tau protein are the main building blocks of the hallmark brain lesions of Alzheimer's disease, though they also appear in other conditions. α-syn is a major constituent of Lewy bodies, protein clumps that are the hallmark of Parkinson's disease and Dementia with Lewy Bodies.

Filippo Baldacci, MD, of the Department of Clinical and Experimental Medicine, University of Pisa, Italy, and the Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital in Paris, and colleagues sought to discover whether concentrations of α-syn and its combinations with amyloid and tau (α-syn/Aβ and α-syn/tau) in red blood cells can accurately discriminate people with Alzheimer's from healthy individuals.

Levels of α-syn, α-syn/Aβ and α-syn/tau were analyzed in 39 people with early-stage Alzheimer's and 39 age-matched healthy controls. Alzheimer's patients received a biomarker-based diagnosis (CSF Aβ and CSF total-tau and/or phospho-tau; alternatively, a positive brain amyloid PET scan).

The researchers found that people with Alzheimer's in the study had lower concentrations of α-syn, α-syn/Aβ and α-syn/tau in red blood cells (RBC) than controls. RBC α-syn/Aβ and RBC α-syn/tau discriminated people with Alzheimer's from healthy controls with "fair accuracy" (AUROC=0.76, 0.72, respectively). RBC α-syn was less accurate (AUROC=0.63).

"Our results showed that people with Alzheimer's had much lower concentrations of α-synuclein and its combinations with amyloid and tau in their red blood cells, compared to healthy individuals," Baldacci said. "With further research and confirmation, this may prove to be a good tool to identify people with Alzheimer's. We have experiments in progress now to verify its ability to discriminate Alzheimer's from other brain diseases, such as Lewy body dementia or Parkinson's dementia."

"Red blood cells may represent workable and relevant models of neurodegeneration since they are likely to be involved in the accumulation and clearance of the misfolded proteins," Baldacci added.

Plasma Neurofilament Light Distinguishes Multiple Diseases from Healthy Controls
Neurofilament light (NfL), also known as neurofilament light chain, is being actively investigated as a biological marker for neurodegeneration in cerebrospinal fluid and plasma in a variety of neurological disorders, including Alzheimer's disease and other dementias.

Abdul Hye, PhD, of the Institute of Psychiatry, Psychology & Neuroscience, King's College London (KCL) says, "Although blood NfL differences between aged-matched controls and disease patients are widely accepted, there has so far been limited research into how concentrations of NfL differ across neurodegenerative disorders."

As reported at AAIC 2019, Hye and colleagues at KCL, Lund University and University of Gothenburg led a multi-center international study to compare the levels of blood NfL across multiple neurodegenerative/neurological conditions. In the study, the original group (n=1,465; BioFINDER from Lund University) and a second independent cohort (n=852; KCL), included people with mild cognitive impairment (MCI), Alzheimer's disease, frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), Parkinson's disease (PD), primary tauopathies and healthy elderly controls. In addition, several other conditions such as vascular dementia, Down syndrome (DS), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and clinical depression were included.

The researchers found that NfL was significantly increased in eight neurodegenerative conditions including Alzheimer's, FTD, DLB, corticobasal syndrome (CBS), ALS and Down syndrome with dementia (DS-D), compared to the control group. Similar results were observed for both study groups. They subsequently generated an NfL concentration cut-off point (in the BioFINDER study group) to attempt to distinguish what was considered normal and abnormal; this was then tested in the KCL cohort.

The scientists found that only 2% of the healthy controls had abnormal NfL levels, which strengthened the choice of cut-off point. The cut-off point identified these groups as those in the study with the highest NfL concentrations: ALS (82%), DS-D (100%), CBS (53-67%) and FTD (40-63%). In both study groups, only between 16-20% of people with Alzheimer's would cross the threshold of abnormal NfL. The researchers say they have replicated this Alzheimer's finding in the Alzheimer's Disease Neuroimaging Initiative data.

"For the first time we have shown that NfL on its own is able to distinguish several neurodegenerative conditions when compared to healthy controls," Hye said. "These results hold promise for the use of NfL as a diagnostic tool and in clinical trials."

"Though, as previously seen in other studies, NfL is not specific for any condition, with validation it could be valuable as a relatively inexpensive and fast test for accumulating neurodegeneration in the brain," Hye added.

About the Alzheimer's Association International Conference (AAIC)
The Alzheimer's Association International Conference (AAIC) is the world's largest gathering of researchers from around the world focused on Alzheimer's and other dementias. As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.
AAIC 2019 home page: www.alz.org/aaic/

AAIC 2019 newsroom: www.alz.org/aaic/pressroom.asp

About the Alzheimer's Association
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. Visit alz.org or call 800.272.3900.

  • Akinori Nakamura, MD, PhD, et al. What Kind of Information Does the Plasma Amyloid-β Biomarker Tell Us? (Funder(s): Japan Agency for Medical Research and Development)
  • Filippo Baldacci, MD, et al. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease. (Funder(s): PRA Health Sciences, Inc.)
  • Abdul Hye, PhD, et al. Plasma Neurofilament Light a Pan-Neurodegenerative Marker. (Funder(s): National Institute for Health Research (NIHR); European Research Council; Swedish Research Council; Knut and Alice Wallenberg Foundation; Marianne and Marcus Wallenberg Foundation; Swedish Alzheimer Foundation; Swedish Brain Foundation; Parkinson Foundation of Sweden; Skåne University Hospital Foundation; Swedish federal government.)

Logo - https://mma.prnewswire.com/media/946692/aaic19_4c_nobox.jpg

More News by PR Newswire India

Second Edition of TechLaw.Fest Addresses Challenges Surrounding Data Access and Control, Data Security, 5G, and the Role of Data in Commerce

BloombergNEF Awards Sungrow a 100% Bankability Rating

"Borderline" Becomes Southeast Asia's First Contemporary Artwork to be Acquired by France's Guimet Museum

Global market of dietary supplement is welcoming a rising star GLYMATE

Artprice by Art Market: Latest Auction Records in Photography

Sungrow Supplies Argentina's Largest Solar Plant with 1500Vdc Central Inverter Solutions

Over 120 Exhibitors From 10 Countries to Participate in Food & Hotel India 2019

SOTC Launches Holidays to Western Australia

Sonata Software Limited Announces Partnership With Agastya International Foundation to Support Creativity and Innovative Thinking in Rural Schools

Garuda Mall Presents Bengaluru's Biggest Doll and Book Festival August 2019

IIHM Initiative for 'Freedom From Hunger' on Independence Day

Xinhua Silk Road: Tasly remains China's 2019 National Tech Innovation Demonstration Enterprise

The Garment Manufacturers Association in Cambodia (GMAC) urges the EU to maintain the EBA program - The livelihood of 750,000 workers and the welfare of some 3 million Cambodians at stake

Venus Concept Announces Financial Results for the Second Quarter and First Six Months of 2019 and FDA 510(k) Clearance of Venus Bliss™

HHL Leipzig Graduate School of Management Confers Honorary Doctorate to Federal Chancellor Angela Merkel

IHG® Hotels & Resorts Serves Up One-of-a-Kind Experiences at 2019 US Open

Earlier Is Better ... New, Patented At-Home Blood Pregnancy Test, Available Exclusively From TAEUS, Offers Human Pregnancy Confirmation Within Days, Rather Than Weeks

Frost & Sullivan Recognizes Proofpoint as the Global Email Security Market Leader for Fifth Consecutive Year

IBC2019: TVU Networks Announces Advances in AI, 4K60fps and HDR Transmission, and Remote Production

Rain Carbon Begins Commissioning Process at New Hydrogenated Hydrocarbon Resins Facility in Germany

AntWorks and Everest Group Unveil Intelligent Document Processing Playbook

Charkit Chemical Announces Promotion Of Panos Yannopoulos To Executive Vice President, Sales

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

Grammy Winning and Multi-Platinum Recording Artist Ariana Grande Launches Her New Fragrance THANK U, NEXT

Amplitude launches Engage, a behavioral targeting solution for automated campaign personalization

Webb Fontaine Group FZ-LLC Signs a National Single Window Implementation Contract With the Government of Nepal

upGrad Honours the Indian Armed Forces With an Exclusive Lifelong Benefit, This Independence Day

Mishtann Foods Reports 22.1% Increase in Q1FY2020 PAT at INR 3.14 Crore

Gyrfalcon's Cutting-edge Technology for Creating AI Accelerator Chips Commended by Frost & Sullivan

Rolls Royce's Ghost Zenith Collection, the Pinnacle of a Timeless Masterpiece

CleverTap Helps GiftAMeal Increase the Number of Meal Donations by 2x

TÜV SÜD South Asia Introduces Promotional Scheme Offering Testing Services With 8- hours Turnaround Time for Textile Manufacturers in Tiruppur

Over 300 Exhibitors & 650 Brands From Gems & Jewellery Industry to Participate in 8th Edition of Delhi Jewellery and Gem Fair ( DJGF ) 2019

9stacks Wins the SuperStartup Asia Award 2019

Mobileum Inc. Acquires WeDo Technologies

true balance and ICICI Lombard Partner to Provide Financial Inclusion to the Next Billion

Ashraya Hastha Trust Partners With Smile Train India to Boost Cleft Care Ecosystem in India

Radio Nasha Celebrates 25 Years of 'Hum Aapke Hain Koun' at Nasha Premiere Nights

Bitfinex Enables Intermediate Verification Level

Small-satellites and Downstream Digital Transformation Accelerate Space Industry Evolution

Uflex Starts Q1 FY2019-20 With a Steady Performance

Vanita Bhandari Takes Over as 50th President of IMC's Ladies' Wing

Jet Midwest, Inc. Acquires a B767-200ER airframe and CF680A-2 engine

42Gears Named as a Visionary in Gartner's Magic Quadrant for Unified Endpoint Management Tools 2019

Richardson Launches Enhanced Service Through Consultative Sales Training Program to Equip Service Professionals with Skills to Deliver Exceptional Customer Experience & Unexpected Value

Chef Clement D'Cruz of Hyatt Joins IIHM Panel of Experts

Voltaiq Applauded by Frost & Sullivan for its Game-changing Battery Analysis Platform, Voltaiq Core, and Innovative Battery Digital Twin Solution

Private and SME Segments Stand Out Globally as Key Targets for Car Leasing Companies

ITC Infotech and 'Automation Anywhere' Pioneer Digital Workforce

Clarivate Analytics launches Cortellis Digital Health Intelligence, a first-of-its-kind solution covering the global digital health ecosystem

Combined Surgical Suction/Irrigation Technology Available Immediately

FDI Applications More Than Doubled in First Half of 2019, Thailand BOI says

Mambu Earns Acclaim from Frost & Sullivan for Accelerating Customers' Time-to-market with its Cloud-based Core Banking Platform

Mukta Arts' Q1 FY20 Consolidated Revenues up 40% y-o-y to INR 47.9 Crore

Prozone Intu's Q1 FY20 Consolidated Revenues up 31.4% to INR 22.3 Crore

Companies Invest Heavily in Employee Health Management IT Solutions to Improve Employees' Well-Being and Corporate Performance

Sofyx & Servify Team Up to Launch Protection Plans for Smartphones in General Trade

OPPO Announces Discounts on F11 Pro and F11 This Independence Day

udChalo Forays Into the Hotel Segment by Partnering With Oyo and Fab Hotels

One Tree Can Save the World - InitiativeTree Launches Its Worldwide Network Tree Planting Program

Global Construction Additives Market Set for Robust CAGR of 6.6% from 2018 to 2025

The Farm at San Benito, Philippines Offers Special Monsoon Packages for Indian Travellers

Saksoft Q1Y20 EBITDA at Rs. 16.17 Crs, a Growth of 40.2% Y-o-Y

UST Global Announces Strategic Partnership With SeaLights Technologies

Pennar Industries Reports 25.8% y-o-y Increase in Q1 FY2020 Consolidated PAT After Minority Interest at INR 16.5 Crore

Global Alliance for the Future of Food Report: 21 Inspiring Examples of a Sustainable Food Future

New Review Suggests Normal Use of Electronic Cigarettes is Unlikely to Raise Significant Health Concerns

Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones

Concept Medical Inc. Granted 2nd 'Breakthrough Device Designation' From the FDA for Its MagicTouch PTA Sirolimus Coated Balloon, for the Treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK) Indication

Betway Partners With Cricket Legend Kevin Pietersen

Higher Levels of Automation Expand Revenue Potential for Analytical Instrumentation Manufacturers

Xinhua Silk Road: Inaugural Fortune Global Sustainability Forum to be held in SW China's Yuxi in early Sept.

Autonomous Vehicle Developers Bet on Sensor Fusion Solutions and L2+ Features

KSB is First Reactor Coolant Pump Manufacturer to be Certified for Modern Nuclear Power Plants in China

Diabetic Patients Face a High Risk of Viral Hepatitis, Over 300 Million Infected HBV Patients are Unaware of Their Status, Says Dr. Nagaraj.S, Infilife Healthcare Pvt. Ltd.

Embassy Office Parks REIT Announces First Quarter FY 2019-20 Results; Reports Quarterly Distribution of Rs 4,167 Million

The Stars Group Reports Second Quarter 2019 Results; Updates 2019 Full Year Guidance; Appoints New Independent Director

Taiwan Tourism Bureau gets on Track With the Mumbai Metro

New Lagavulin 10 Year Old Single Malt Scotch Whisky: A Rare and Exclusive Treat for Travellers

Amity University Maharashtra Hosts its First Annual Convocation Ceremony in Mumbai

Producer Gaurang Doshi has been Instrumental in the Launch and Success of Many Among 'A' List Bollywood; Plans to Launch Ace Talent yet Again

MEIL's Engineering Marvel Converts Telangana's Dream Into a Reality

Deutsche Messe AG Alliance with Donghao Lansheng Group to Launch New Industrial Fairs in Shenzhen and Chengdu from 2020

Children Learn to Become Global Leaders at the 2019 Eye Level Model United Nations Camp

HONOR Vision Defines the Future with HONOR "Sharp Tech" Innovations

116 Young Talents for the 3rd Zhuhai Mozart Competition in September

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Triple talaq 'un-Islamic', not supported...
Telangana government neck-deep in corrup...
Telangana: Around 60 prominent TDP leade...
Yediyurappa awaits Shah's nod to expand ...
Malnutrition bigger threat than Maoists:...
Leh's Magnetic Hill: Myth or Real?...
More...    
 
 Top Stories
Over 20 killed in oil tanker explos... 
US condemns 'barbaric' terror attac... 
Ashes: Australia cling on to draw d... 
Pak government presents first anniv... 
Despite bill on triple talaq women ... 
UN chief condemns bomb attack on we... 
UN appeals for more help to allevia... 
C'garh couple accuses nurse of medi...